Infection of A431 cells with vaccinia virus, or exposure to a mitogenic polypeptide secreted by vaccinia virus-infected cells, induces tyrosine phosphorylation of epidermal growth factor receptors. An open reading frame that is present twice in the DNA genome of the poxvirus vaccinia virus (VV), is predicted to encode a polypeptide of 15.5 kilodaltons (37) . A 50-amino acid portion of the predicted peptide is related in sequence to epidermal growth factor (EGF) and transforming growth factor (TGF) type ao (1, 2, 23) . Human EGF and rat TGFot show about 40% amino acid homology, and all cysteines, which are known to be important for the secondary structure of EGF (16) , are found in homologous positions in TGFa (21) . Both EGF and TGFt can bind to EGF receptors, both are mitogenic for appropriate cells, and both can act via EGF receptors to promote the growth of normal cells in soft agarose containing TGFP (3, 32) . Since the VV sequence is as closely related to EGF as EGF is to TGFox, and since in particular the disposition of cysteines is conserved, it has been suggested that the VV sequence codes for a growth factor (1, 2, 23).
The VV gene described above is transcribed early in infection of HeLa cells, producing a 620-nucleotide mRNA that can be translated in vitro to yield a polypeptide of about 19 kilodaltons (7) . A similar RNA is found in cells infected by another poxvirus, rabbit poxvirus (7) . Recently, a 25-kilodalton glycoprotein (vaccinia growth factor [VGF] ) that can bind to EGF receptors has been purified from media of VV-infected BSC-1 cells (34) . VGF competes with EGF or TGFt for binding to EGF receptors, and like EGF and TGFt it is mitogenic, yet it is distinguishable from EGF and TGFao by immunological and physical criteria (34) . Direct genetic and structural evidence has now been obtained that VGF is the product of the VV gene possessing homology with EGF and TGFox (31; D. R. Twardzik, H. Marquardt, G. J. Todaro, and B. Moss, manuscript in preparation).
The EGF receptor has a tyrosine protein kinase activity that is stimulated by EGF (36) . Addition of EGF to human tumor A431 cells, which have a superabundance of EGF receptors (11) , stimulates protein phosphorylations at serine, threonine, and tyrosine (17) . Phosphate labeling of the EGF receptor at serine and threonine increases by about 100%, but phosphate labeling at tyrosine increases by at least 300% (17) . Tyrosine phosphorylation of EGF receptors in EGFtreated fibroblasts has also been detected (9) . Most of the phosphotyrosine is found at a single position in the EGF receptor, now identified as tyrosine 1173 (10) . This tyrosine is among several that are autophosphorylated in vitro when purified EGF receptors are incubated with EGF and ATP (10) . Under (19) . One such phosphorylation site, now identified as threonine 654 (8, 18, 22) , can also be phosphorylated by protein kinase C in vitro (5) , and its phosphorylation in EGF-stimulated cells is probably a consequence of activation of protein kinase C when membrane phospholipid turnover is stimulated by EGF (25, 26) . Protein kinase C can also be activated in vitro by the tumor promoter tetradecanoyl phorbol acetate (TPA), and TPA promotes phosphorylation of EGF receptors at threonine 654 when added to A431 cells or fibroblasts (4, 5, 8, 9, 13, 19) .
In this paper was added to 32P,-labeled A431 cells for 30 min; the inoculum was then removed and the radioactive medium was replaced together with cytosine arabinoside, which inhibits viral DNA synthesis. Synthesis of early viral RNAs, including the mRNA for the 19-kilodalton polypeptide, is increased in the presence of cytosine arabinoside (38) , and titers of VGF secreted into the media are likewise increased (34) . Infection with 20 PFU of VV per cell induced tyrosine phosphorylation of the EGF receptor by 4.5 h after infection, and infection with 2 PFU per cell induced a smaller increase (Table 1) . EGF receptors from cells infected with 0.2 PFU per cell contained amounts of phosphotyrosine that were too small to quantify but were detectable visually on the autoradiogram. Previous experiments have shown that VGF production increases with multiplicity of infection with VV (34) .
To investigate whether the tyrosine phosphorylation stimulated by VV infection involved EGF receptors accessible at the cell surface, we used a monoclonal antibody, 528 IgG, which recognizes an extracellular epitope of the human EGF receptor and inhibits more than 95% of EGF binding to A431 cells (20) . Addition of 528 IgG for the time interval betwee: 0.5 and 4.5 h after infection with VV prevented most of the increase in phosphotyrosine in EGF receptors ( Table 1) .
Next we examined the effects of purified VGF on the phosphorylation state of the EGF receptor. A431 cells were labeled with 32p; for 15 to 18 h, enabling most protein phosphates to reach equilibrium, and then exposed to EGF (0.5 nM) or a similar EGF-competing concentration of highpressure liquid chromatography-purified VGF. After 10 min, EGF receptors were isolated by immunoprecipitation. Phosphoamino acid analysis showed that VGF, like EGF, stimulated tyrosine phosphorylation of the receptor (Fig. 1A  through C, insets) . Tryptic peptide mapping revealed that both EGF and VGF induced phosphorylation of the EGF receptor at the peptide containing tyrosine 1173 (peptide 1, Fig. 1A through C) . Both factors also stimulated phosphorylation at two related peptides (X and Z, Fig. 1A through C) that were also detected in receptors of TPA-treated cells (Fig. 1D ) and contain threonine 654 as the only hydroxyamino acid (18) . Accordingly, it appears that VGF stimulates autophosphorylation of the EGF receptor at tyrosine 1173 and activates phosphorylation of the EGF receptor by a protein kinase with identical specificity to protein kinase C.
In most experiments, VGF induced less extensive phosphorylation than EGF, but in some experiments VGF was equally active. The VGF concentration was estimated from competition binding measurements before use in phosphorylation experiments. VGF is relatively hydrophobic, however, and appears to lose potency, perhaps through aggregation or adsorption to surfaces. Since our experiments were performed with amounts of EGF that are not saturating for stimulation of tyrosine phosphorylation (17) , variation in the amount of VGF added could be significant. When sufficient purified VGF is available, it will be possible to test whether the maximal phosphorylation with VGF equals the maximal phosphorylation with EGF.
One consequence of exposure of A431 cells to TPA is an inhibition of tyrosine phosphorylation upon subsequent EGF addition (5, 13) . Likewise, stimulation of EGF receptor phosphorylation on tyrosine by VGF was prevented by prior exposure of cells to TPA (Fig. 1E) .
When cell surface EGF receptors were rendered inaccessible with 528 IgG, subsequent induction of receptor phosphorylation at tyrosine in response to either VGF or EGF (1.7 nM) was inhibited ( (12, 27) . It is possible that the three growth factors resolved by electrophoresis at pH 8.9 (anode at left) and ascending chromatography. Thin-layer plates were exposed for 2 to 2.5 days (radioactivity analyzed ranged from 3,000 to 4,000 cpm Cerenkov). Parts A, C, and D were from one experiment; B and E were from another experiment in which an untreated control appeared similar to A, but in which the effects of EGF and of TPA alone were not tested. Peptide 1 phosphorylation in response to VGF was routinely observed, but the extent of phosphorylation was variable, probably because of variation in the amount of VGF added (see text). Large arrowheads: Points of sample application. Small arrowheads: Positions of peptides 1, X, and Z. Acid digestion of phosphopeptide 1 from VGF-treated cells released phosphotyrosine, and phosphothreonine was found in phosphopeptide Z (data not shown).
and the two antibodies all induce the same conformational change in the EGF binding domain. Alternatively, perhaps different conformational changes in the binding domain, outside the cell, all translate into the same change in the kinase domain, inside the cell, resulting in kinase activity. Indeed, the type of signal that may be transmitted across the plasma membrane from binding domain to kinase domain may be limited to on or off, given the apparently monomeric, simple structure of the EGF receptor (15, 35) . It is useful to compare the production of VGF and TGFa after infection with VV and various acute transforming retroviruses, respectively (33) . VGF is encoded by VV, but TGFa is encoded by the cell and secreted in response to transformation. Whereas VGF is released into the culture medium, TGFa is not always detectable in the medium from transformed cells. It may be produced but then become adsorbed quantitatively to the EGF receptors of the cell in which it is synthesized. Since some intracellular EGF receptors are probably functional (29, 39) , nascent TGFa could bind to EGF receptors totally within the cell. Such TGF may never leave the cell, but instead be degraded together with the receptor to which it is bound. This may be the case with A431 cells infected with Harvey or Kirsten murine sarcoma virus or Snyder-Theilen feline sarcoma virus, since TGFa was not detected in the culture media (6) . Production of TGFa was inferred from the observation that EGF receptor number was decreased more than 70% in the infected cells, and receptors were degraded at a rate approaching that found when uninfected A431 cells were exposed to EGF (6) . Tyrosine phosphorylation of EGF receptors was not detected, in accord with the low level of tyrosine protein kinase activity in A431 cells exposed for long periods to EGF (17) .
In contrast, VV infection of BSC-1 cells induces consid- 
